Nov 27 (Reuters) - Shanghai Henlius Biotech Inc
:
* APPLICATION FOR CLINICAL TRIAL OF HLX43 FOR INJECTION FOR TREATMENT OF ADVANCED/METASTATIC SOLID TUMOURS APPROVED BY US FDA
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Nov 27 (Reuters) - Shanghai Henlius Biotech Inc
:
* APPLICATION FOR CLINICAL TRIAL OF HLX43 FOR INJECTION FOR TREATMENT OF ADVANCED/METASTATIC SOLID TUMOURS APPROVED BY US FDA
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Comments